An AIDS patient, who is being treated with multiple drugs, develops breast hypertrophy, central adiposity, hyperlipidemia, insulin resistance
and nephrolithiasis. If these changes are related to his drug treatment, this drug belongs to which group of anti-retroviral drugs?
a) Nucleoside Reverse Transcriptase Inhibitors (NRTIS)
b) Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIS)
c) Fusion Inhibitors
d) Protease Inhibitors
e) Integrase Inhibitors
1. A 35 year old HIV positive male patient comes to the OPD with complaint of anorexia, nausea and vomiting and abdominal pain. His
abdomen is tender in the epigastric area. Laboratory results reveal a raised serum amylase activity and a preliminary diagnosis is made of acute
pancreatitis. Which of the following anti-retroviral drugs has the patient most likely been taking?
a) Saquinavir
b) Zidovudine
c) Didanosine
d) Efavirenz
e) Enfuvirtide
2. A 40 year old HIV positive patient is receiving HAART regimen (Highly active anti-retroviral therapy). Four weeks after initiating therapy, he
comes to the emergency department complaining of severe pain in the flank, nausea and frequent urination. Which one of the following drugs is
most likely the cause of his symptoms?
a) Zidovudine
b) Indinavir
c) Efavirenz
d) Nevirapine
e) Nelfinavir
3. A 30 year old man is recently diagnosed with HIV and therapy is started. After the first week of therapy, the patient complains of headaches,
irritability, and nightmares. Which one of the following anti-retroviral drugs is most likely to be causing these symptoms?
a) Efavirenz
b) Indinavir
c) Lamivudine
d) Nevirapine
e) Stavudine
4. A 35 year old woman is diagnosed with chronic hepatitis B infection and therapy is initiated. Just after a few hours she comes to the
emergency department complaining of fever, chills and muscle aches. Which one of the following drugs most likely caused these symptoms?
a) Lamivudine
b) Adefovir
c) Entecavir
d) Interferon alfa
e) Ribavirin
6. A 60 year old man with known history of Parkinson’s disease is to receive prophylaxis against Influenza A virus. He is given a drug that is
useful against Parkinson’s disease as well for prophylaxis against influenza. The drug with which of the following mechanisms of action is most
likely to have been given?
Q18. Telithromycin:
a) Is structurally related to tetracycline
b) Is structurally related to beta lactam antibiotics
c) Is structurally related to aminoglycosides (note: see an animation on aminoglycosides mechanism of action)
d) Binds more tightly to ribosomes and so it is a poor substrate for bacterial efflux pumps that mediateantibiotic resistance
e) Is used for UTI
Q19. Doxycycline is used:
a) for Pneumonia as drug of 1st choice
b) for the prevention of TB
c) for the prevention of malaria
d) for the prevention of leprosy
e) for the treatment of sexually transmitted diseases
Q20. Clindamycin:
a) is chemically related to macrolides
b) binds to 30S ribosomal subunit
c) is not recommended for oral route
d) cross-resistance may be observed between macrolides and Clindamycin
e) is excreted in breast milk
Q25. A 12 years old female patient came to pediatrician suffering from headache, high grade fever, moderate chest pain, joint pain and drowsy.
When doctor got history, he was told to take diazepam 2.5 mg by patient 15 hours ago. Actually it was already a diagnosed case of pneumonia
and she was on drug treatment including streptogramin. Concerning streptogramins, which one of the following statements is false:
a) they are active against methicillin-resistant staphylococci
b) they may cause a syndrome of arthralgia and myalgia
c) they are used in the management of infections caused by vancomycin-resistant enterococci
d) they are associated with post antibiotic effect
e) they induce formation of hepatic drug-metabolizing enzymes
Q26. Telithromycin:
a) is cell wall synthesis inhibitor
b) is a ketolide structurally related to macrolides
c) it binds very loosely to ribosomes so it is good substrate for bacterial efflux pumps that mediate resistance
d) is used in Lyme disease mainly
e) is used in pneumonia as drug of 1st choice
Q28. A 33 years old male patient has been diagnosed mycoplsma pneumoniae infection. He was treated by one of the broad spectrum
antibacterial drug group tetracycline 2 gram TID for 21 days. What may be most appropriate toxicity?
a) anemia
b) hepatic necrosis
c) thrombocytosis
d) alopecia
e) sleeplessness
Q29. an elderly debilitated patient has a fever believed to be due to an infection. He has extensive skin lesions, scrapings of which reveal the
presence of large numbers of gram-positive cocci. The most appropriate drug to use for treatment of this patient is:
a) amoxicillin
b) salbactam
c) cefoxitin
d) nafcillin
e) penicillin G
Q30. A 21 year old man was seen in a clinic with a complaint of dysuria and urethral discharge of yellow pus. He has a painless clean-base ulcer
on the penis and nontender enlargement of the regional lymph nodes. Gram stain of the urethral exudates showed gram negative diplococci
within polymorphonucleocytes. The patient informed the clinic staff that he was unemployed and had not eaten a meal for two days. The most
appropriate treatment of gonorrhea in this patient is:
a) amoxicillin orally for 7 days
b) vancomycin intramuscularly as a single dose
c) ceftriaxone intramuscularly as a single dose
d) tetracycline orally for 7 days
e) procaine penicillin G intramuscularly as a single dose plus one gram of probenecid
Q31. Eighty years old male patient having 73 Kg body weight was suffering from fever, headache and lumbar pain since last 7 days. He was
examined in clinic. Gram stain of the smear of CSF revealed gram positive rods resembling diphtheroids. The antibiotic regimen for empiric
treatment would include:
a) Erythromycin
b) Ticarcillin
c) Cefotetan
d) Cefazolin
e) Ampicillin
Q32. A 25 year old male presents to the medical OPD with complaint of cough and low grade fever since the last 3 months. Laboratory tests
show sputum positive for acid fast bacteria. Which of the following combination of drugs is most likely to be administered at the start to this
patient?
a) Streptomycin, Isoniazid, Rifampicin and Pyrazinamide
b) PAS, Pyrazinamide and Rifampicin
c) Pyrazinamide, Ethambutol and Isoniazid
d) Streptomycin and Rifampicin
e) Streptomycin alone
Q33. A 25 year old male has been given treatment for pulmonary tuberculosis for 2 months as initial phase. Now he comes to the OPD for
medication for the continuation phase. Which of the following drugs will he most likely be given for the continuation phase?
a) Pyrazinamide and Isoniazid
b) Ethambutol and Streptomycin
c) Isoniazid and Rifampicin
d) Rifampicin and Streptomycin
e) Ethambutol and Pyrazinamide
Q34. A young man 26 years old is started treated for pulmonary tuberculosis. He comes to the medical OPD after 1 week with complaint of
orange red colored urine and sweat and tears. Which of the following drugs is most likely causing these symptoms?
a) Streptomycin
b) Rifampicin
c) Ethambutol
d) Pyrazinamide
e) Thiacetazone
Q35. A 30 year old male with known TB infection and taking medication since 1 month comes to the Eye OPD with complaint of visual
disturbances including decreased visibility and slight color blindness. If these symptoms are due to his drug treatment, which one of the
following drugs is most likely the cause of his symptoms?
a) Streptomycin
b) Ciprofloxacin
c) Ethambutol
d) Rifampicin
e) Isoniazid
Q36. A 35 year old male recently diagnosed with tuberculosis and is started on medication. After a few days he comes to the emergency
department a few hours after taking a meal at McDonald’s with severe pain in the big toe. Blood tests show a very high uric acid level. Which of
the following drugs most likely caused these symptoms?
a) Streptomycin
b) Rifampicin
c) Isoniazid
d) Amikacin
e) Pyrazinamide
Q37. A 40 year old male taking medication for tuberculosis since the last 2 months comes to the ENT OPD with complaint of hearing problems
and ringing in the years. The drug with which of the following mechanisms of action is most likely causing these symptoms?
a) Binds to 30 S Ribosome subunit & inhibits initiation complex
b) Inhibits DNA Dependent RNA Polymerase
c) Inhibits synthesis of mycolic acid
d) Inhibits synthesis of arabinoglycan subunits
e) Inhibits DNA Gyrase
Q38. A 35 year old female taking medication for tuberculosis and oral contraceptives comes to the Gynaecology OPD with complaint of
amenorrhea. Laboratory test shows a positive pregnancy test. Which one of the following drugs most likely caused her to become pregnant?
a) Rifampicin
b) Pyrazinamide
c) Streptomycin
d) Ethambutol
e) Isoniazid
Q39. A 45 year old male with diagnosed chronic liver disease gets infected with the tuberculosis. Which one of the following drugs would be
most safe for this patient for the treatment of tuberculosis?
a) Isoniazid
b) Rifampin
c) Pyrazinamide
d) Ethambutol
e) Ethionamide
Q40. A 48 year old male is diagnosed with tuberculosis and has been treated for 2 months with isoniazid and rifampicin with good response. But
the patient develops numbness and paresthesias in the extremities. What will you most likely do next?
a) Add pyridoxine
b) Stop isoniazid
c) Add vitamin E
d) Replace rifampin with ethambutol
e) Replace isoniazid with streptomycin
Q41. A 30 year old male presents with history of fever occurring in a step-ladder fashion for the last 10 days. He also feels abdominal pain after
taking meals. Lab tests show decreased TLC count and a positive Widal test. The drug which is most likely to be given acts by which one of the
following mechanisms?
a) Ciprofloxacin
b) Ampicillin
c) Cotrimoxazole
d) Cefixime
e) Azithromycin
Q42. A 35 year old pregnant woman presents to the gynecology department with complaint of pain with rising fever since the last 5 days. Lab
tests show gram negative bacilli and widal test comes out positive. Which one of the following drugs will most likely be administered?
a) Ciprofloxacin
b) Levofloxacin
c) Ofloxacin
d) Norfloxacin
e) Ampicillin
Q43. A 27 year old male football player gets injured in a match. He comes to the emergency department with pain and swelling near the ankle.
On examination, there is small wound with a tender swelling near the ankle joint. Further tests reveal tendon rupture with tendonitis setting in.
Which one of the following antibiotics, if required, will most probably not be given to this patient?
a) Ceftriaxone
b) Clarithromycin
c) Aminoglycoside
d) Ciprofloxacin
e) Amoxicillin
Q44. A 40 year old male comes to the medical OPD with symptoms of cough & fever for the last few days. Sputum culture shows presence
of gram positive cocci. Which one of the following Fluoroquinolones is most likely to be administered to this patient?
a) Ciprofloxacin
b) Norfloxacin
c) Ofloxacin
d) Gatifloxacin
e) Levofloxacin
Q45. A 50 year old patient comes to the emergency department, a day after he has been administered an antibiotic for an on-going infection,
with complaint of palpitations. ECG reveals prolonged QT interval. Which one of the following Fluoroquinolones most likely caused this adverse
effect?
a) Ciprofloxacin
b) Norfloxacin
c) Levofloxacin
d) Ofloxacin
e) Gatifloxacin
Q47. A patient with watery stools is diagnosed as suffering from amebic dysentery. He is given a drug that causes a metalic taste in the mouth
which drug may be given.
a) Iodoquinol
b) Diloxanide furate
c) Metronidazole
d) Pentamiline
e) Emetine.
Q48. The reason for giving Metronidazole for oropharyngeal infection is due to its good activity against:
a)Gram positive cocci
b)Gram Negative cocci
c)Gram positive bacilli
d)Gram negative bacilli
e)Anaerobes like B. fragilis
Q49. Patient comes to emergency with the complaints of marked visual and auditory abnormities, vomiting diarrhea abdominal pain & skin
rashes. From the history of the patient it was revealed that he took some drug for the treatment of fever. What could be probable diagnosis?
a)Cinchonism
b)Acute gastro enteritis
c)Cholera
d)Typhoid fever
e)Acid peptic disease
Q50. A 37 year old male is having repeated episodes of fever with chills with blood smear positive for malaria since last one year. He was given
chloroquine each time & the fever subsided. Which of the following drugs would you add with chloroquine this time?
a)Artemether
b)Mefloquine
c)Malarone
d)Primaquine
e)Halofantrine
a) Aqueous diffusion
b) Lipid diffusion
c) Carrier molecules
d) Endocytosis and exocytosis
5.2) Which of the following drug permeation mechanisms occurs across epithelial tight
junctions and is driven by a concentration gradient?
a) Aqueous diffusion
b) Lipid diffusion
c) Carrier molecules
d) Endocytosis and exocytosis
5.3) Which of the following drug permeation mechanisms uses the Henderson-
Hasselbalch equation for the ratio of solubility for the weak acid or weak base?
a) Aqueous diffusion
b) Lipid diffusion
c) Carrier molecules
d) Endocytosis and exocytosis
5.4) Which of the following drug permeation mechanisms is used for peptides, amino
acids, glucose, and other large or insoluble molecules?
a) Aqueous diffusion
b) Lipid diffusion
c) Carrier molecules
d) Endocytosis and exocytosis
5.5) Which of the following drug permeation mechanisms uses caveolae?
a) Aqueous diffusion
b) Lipid diffusion
c) Carrier molecules
d) Endocytosis and exocytosis
6.1) Using the Fick Law of Diffusion, how will flux change if membrane thickness is
doubled?
a) It will double
b) It will quadruple
c) It will halve
d) It will quarter
e) It will not change
6.2) Using the Fick Law of Diffusion, how will flux change if the permeability
coefficient is quadrupled?
a) It will double
b) It will quadruple
c) It will halve
d) It will quarter
e) It will not change
7.1) Which of the following is the amount of a drug absorbed per the amount
administered?
a) Bioavailability
b) Bioequivalence
c) Drug absorption
d) Bioinequivalence
e) Dosage
7.2) Which of the following is NOT needed for drug bioequivalence?
a) Same active ingredients
b) Same strength or concentration
c) Same dosage form
d) Same route of administration
e) Same side effects
7.3) For intravenous (IV) dosages, what is the bioavailability assumed to be?
a) 0%
b) 25%
c) 50%
d) 75%
e) 100%
7.4) Although morphine (Avinza, Oramorph SR, MS Contin) is well-absorbed when
administered orally (PO), how much of the drug is metabolized on its first pass through
the liver?
a) 90%
b) 70%
c) 50%
d) 30%
e) 10%
7.5) For a generic drug to be bioequivalent to an innovator drug (per FDA), it must be
measured in ____ of subjects to fall within ____ of the mean of the test population
bioavailability.
a) 50; 50
b) 80; 20
c) 20; 80
d) 95; 5
e) 5; 95
7.6) Using the FDA bioequivalence rule, how much variation could a generic drug
potentially have from an innovator and still be considered equivalent?
a) 100%
b) 20%
c) 40%
d) 60%
e) 80%
8.1) Which of the following is NOT a pharmacokinetic process?
a) Alteration of the drug by liver enzymes
b) Drug metabolites are removed in the urine
c) Movement of drug from the gut into general circulation
d) The drug causes dilation of coronary vessels
e) The drug is readily deposited in fat tissue
8.2) Which of the following can produce a therapeutic response? A drug that is:
a) Bound to plasma albumin
b) Concentrated in the bile
c) Concentrated in the urine
d) Not absorbed from the GI tract
e) Unbound to plasma proteins
8.3) Which of the following most correctly describes steroid hormones with respect to
their ability to gain access to intracellular binding sites?
a) They cross the cell membrane via aqueous pores
b) They have a high permeability coefficient
c) They are passively transported via membrane carriers
d) They require vesicular transport
e) Their transport requires the hydrolysis of ATP
3 – Pharmacokinetic Principles: pH and Drug Movement
1) Most drugs are either ____ acids or ____ bases.
a) Strong; Strong
b) Strong; Weak
c) Weak; Weak
d) Weak; Strong
2.1) Aspirin readily donates a proton in aqueous solutions and pyrimethamine readily
accepts a proton in aqueous solution. Thus, aspirin is a(b) ____ and pyrimethamine is
a(n) ____.
a) Acid; Base
b) Base; Acid
c) Acid; Acid
d) Base; Base
2.2) Given the equilibrium HA <=> A- + H+ (acid) and BH+ <=> B + H+ (base), in an
acid environment (low pH) the acid reaction will move to the ____ and the base reaction
will move to the ____.
a) Right; Left
b) Right; Right
c) Left; Right
d) Left; Left
3.1) What form of a drug is more lipid-soluble, and thus would remain trapped within a
compartment where the pH does not favor the lipid-soluble form?
a) Strong acid (A-)
b) Weak acid (A-)
c) Neutral (AH and B)
d) Weak base (BH+)
e) Strong base (BH+)
3.2) The lipid-soluble form of a base is ____ and the lipid-soluble form of an acid is
____.
a) Protonated; Protonated
b) Protonated; Unprotonated
c) Unprotonated; Unprotonated
d) Unprotonated; Protonated Pharmacology – Part 1 Quiz
Version: 16Oct2008 Page 8 of 42
4.1) If the pKa of Aspirin (acetylsalicylic acid) is 3.5 and the pH of the stomach is 2.5,
how much Aspirin is in the protonated species in the stomach and is this the amount
available for absorption?
a) ≈ 91%; Yes
b) ≈ 91%; No
c) ≈ 9%; Yes
d) ≈ 9%; No
4.2) What percentage of Aspirin would be ionized in the blood compartment (pH = 7.4)
assuming pH is 7.5 and Aspirin pKa is 3.5?
a) (10,000 – 1) / 1 = 99.99%
b) (100 – 1) / 1 = 99%
c) None
d) 1 / (100 – 1) = 0.9%
e) 1 / (10,000 – 1) = 0.009%
4.3) If the pH – pKa = -1, what percentage of weak base is nonionized?
a) 99
b) 90
c) 50
d) 10
e) 1
4.4) If the pH – pka = 2, what percentage of weak acid is nonionized?
a) 99
b) 90
c) 50
d) 10
e) 1
4.5) If pH > pKa, the drug is ____ and if pH < pKa, the drug is ____. An unprotonated
acid is ____ and a protonated base is ____.
a) Protonated; Unprotonated; Charged; Charged
b) Protonated; Unprotonated; Neutral; Neutral
c) Unprotonated; Protonated; Charged; Charged
d) Unprotonated; Protonated; Neutral; Charged
e) Unprotonated; Protonated; Charged; Neutral
5.1) Weak acids are excreted faster in ____ urine and weak bases are excreted faster in
____ urine.
a) Acidic; Alkaline
b) Alkaline; Acidic
c) Acidic; Neutral
d) Neutral; Alkaline
e) Alkaline; Neutral
5.2) A patient presents with an overdose of acidic Aspirin. The drug ____ can be given to
____ the pH of the urine and trap the Aspirin, preventing further metabolism.
a) NaHCO3; Increase
b) NaHCO3; Decrease
c) NH4Cl; Increase
d) NH4Cl; Decrease Pharmacology – Part 1 Quiz
Version: 16Oct2008 Page 9 of 42
5.3) A patient presents with an overdose of alkaline Codeine. The drug ____ can be given
to ____ the pH of the urine and trap the Codeine, preventing further metabolism.
a) NaHCO3; Increase
b) NaHCO3; Decrease
c) NH4Cl; Increase
d) NH4Cl; Decrease
6.1) The principle of drug manipulation for excretion of a drug out of the renal tubule can
be accomplished by:
a) Acidifying the urinary pH
b) Adjusting the urinary pH to protonate weakly acidic drugs
c) Adjusting the urinary pH to unprotonate weakly basic drugs
d) Adjusting the urinary pH to ionize the drug
e) By neutralizing the urinary pH
6.2) Aspirin is a weak organic acid with a pKa of 3.5. What percentage of a given dose
will be in the lipid-soluble form at a stomach pH of 1.5?
a) About 1%
b) About 10%
c) About 50%
d) About 90%
e) About 99%
6.3) For which of the following drugs is excretion most significantly accelerated by
acidification of the urine?
a) Weak acid with pKa of 5.5
b) Weak acid with pKa of 3.5
c) Weak base with pKa of 7.5
d) Weak base with pKa of 7.1
6.4) A patient diagnosed with type 2 diabetes is administered an oral dose of 0.1 mg
chloropropamide, an insulin secretagogue and weak acid with a pKa of 5.0. What is the
amount of this drug that could be absorbed from the stomach at pH 2.0?
a) 99.9 µg
b) 90 µg
c) 50 µg
d) 0.05 mg
e) 0.01 mg
1.2) Most drugs are active in their ____ form and inactive in their ____ form.
a) Non-polar; Polar
b) Polar; Non-polar
c) Water-soluble; Lipid-soluble
d) Lipid-insoluble; Water-insoluble
e) Neutral; Neutral
2.1) Drug biotransformation phase I makes drugs ____ polar for metabolism and phase II
makes drugs ____ polar for excretion.
a) More; More
b) More; Less
c) Less; More
d) Less; Less
2.2) Which of the following is NOT a phase II substrate?
a) Glucuronic acid
b) Sulfuric acid
c) Acetic acid
d) Amino acids
e) Alcohol
3) Which of the following reactions is phase II and NOT phase I?
a) Oxidations
b) Reductions
c) Conjugations
d) Deaminations
e) Hydrolyses
4) Which of the following metabolically active tissues is the principle organ for drug
metabolism?
a) Skin
b) Kidneys
c) Lungs
d) Liver
e) GI Tract
5.1) Damage at which of the following locations would most affect the goals of phase II
biotransformation?
a) Skin
b) Kidneys
c) Lungs
d) Liver
e) GI Tract
Match the biotransformation reaction with the drug:
5.2) Hydroxylation of aromatic ring to increase polarity a) Codeine
5.3) N-dealkylation b) Morphine
5.4) Sulfoxidation c) Thioridazine
5.5) O-dealkylation d) Nicotine
5.6) N-oxidation e) Phenobarbitol
5.7) Side chain oxidation with -OH to increase polarity f) Pentobarbitol
5.8) Conversion to glutathione and reactive intermediate g) Acetaminophen
6.1) What is the goal of the P450 system (microsomes pinched off from endoplasmic
reticulum)?
a) Metabolism of substances
b) Detoxification of substances
c) Increasing pH of compartments containing substances
d) Decreasing pH of compartments containing substances
e) A & B
6.2) Regarding the microsomal drug metabolizing system, a patient with late stage
alcoholism and liver damage would have more ETOH available due to which of the
following concepts?
a) Increased induction
b) Decreased induction
c) Increased inhibition
d) Decreased inhibition
6.3) Regarding the microsomal drug metabolizing system, a patient who is a chronic user
of barbiturates would need more drug to produce the same effects due to which of the
following concepts?
a) Increased induction
b) Decreased induction
c) Increased inhibition
d) Decreased inhibition
6.4) Which of the following are the drugs that induce CYP 1A2 and the drugs that have
their metabolism induced by 1A2?
a) Carbamazepine & phenobarbitol; Theophyline & warfarin
b) Phenobarbitol & phenytoin ; Phenytoin & warfarin
c) Carbamazepine & phenytoin; Warfarin
d) Carbamazepine; Cyclosporine
6.5) Which of the following are the drugs that inhibit CYP 1A2 and the drugs that have
their metabolism inhibited by 1A2?
a) SSRIs; Phenytoin & warfarin
b) Amiodarone & cimetidine; Phenytoin & warfarin
c) Cimetidine, erythromycin, & grapefruit juice; Theophyline & warfarin
d) Cimetidine & erythromycin; Cyclosporine
6.6) Which of the following groups of people is the least likely to have biotransformation
effects due to altered hepatic function?
a) Infants
b) Adults
c) Elderly
d) Chronic alcoholics
e) Acetaminophen overdoses
6.7) In what location does amino acid conjugation of glycine (e.g. salicyclic acid) take
place?
a) Microsomal
b) Cytosol
c) Mitochondria
6.8) Where does acetylation conjugation (e.g. isoniazid) and sulfate conjugation (e.g.
acetaminophen) take place?
a) Microsomal
b) Cytosol
c) Mitochondria
6.9) Where does glucuronide conjucation (e.g. digoxin, bilirubin) take place?
a) Microsomal
b) Cytosol
c) Mitochondria
a) Detoxification of liver
b) Detoxification of kidneys
c) Detoxification of blood
d) Detoxification of urine
e) Hepatotoxicity
c) Dopamine (DA)
2.5) Where is the cytosolic catecholamine metabolizing enzyme catechol-O-methyl
transferase (COMT) primarily found?
a) Liver
b) GI tract
c) Placenta
d) Blood platelets
3.1) Which of the following receptor subtypes relaxes smooth muscle and causes liver
glycogenolysis and gluconeogenesis?
a) α1 (Gq/Gi/Go)
b) α2 (Gi/Go)
c) β1 (Gs)
d) β2 (Gs)
e) β3 (Gs)
3.2) Which of the following receptor subtypes causes vascular smooth muscle contraction
and genitourinary smooth muscle contraction?
a) α1 (Gq/Gi/Go)
b) α2 (Gi/Go)
c) β1 (Gs)
d) β2 (Gs)
e) β3 (Gs)
3.3) Which of the following receptor subtypes increases cardiac chronotropy (rate) and
inotropy (contractility), increases AV-node conduction velocity, and increases rennin
secretion in renal juxtaglomerular cells?
a) α1 (Gq/Gi/Go)
b) α2 (Gi/Go)
c) β1 (Gs)
d) β2 (Gs)
e) β3 (Gs)
3.4) Which of the following receptor subtypes decreases insulin secretion from pancreatic
β-cells, decreases nerve cell norepinephrine release, and contracts vascular smooth
muscle?
a) α1 (Gq/Gi/Go)
b) α2 (Gi/Go)
c) β1 (Gs)
d) β2 (Gs)
e) β3 (Gs)
4.1) What type(s) of second messenger(s) interact with adenylyl cyclase?
a) α1
b) α2
c) β
d) β & α1
e) β & α2
4.2) What type(s) of second messenger(s) are associated with phospholipase C (PLC)?
a) α1
b) α2
c) β
d) β & α1
e) β & α2
4.3) Which of the following adrenergic receptor activation mechanisms is involved with
ephedrine, amphetamine, and tyramine?
a) Direct binding to the receptor
b) Promoting release of norepinephrine
c) Inhibiting reuptake of norepinephrine
d) Inhibiting inactivation of norepinephrine
4.4) Which of the following adrenergic receptor activation mechanisms is involved with
MAO inhibitors?
a) Direct binding to the receptor
b) Promoting release of norepinephrine
c) Inhibiting reuptake of norepinephrine
d) Inhibiting inactivation of norepinephrine
4.5) Which of the following adrenergic receptor activation mechanisms is involved with
tricyclic antidepressants and cocaine?
a) Direct binding to the receptor
b) Promoting release of norepinephrine
c) Inhibiting reuptake of norepinephrine
d) Inhibiting inactivation of norepinephrine
4.6) Which of the following is NOT true of catecholamines?
a) Non-polar
b) Cannot cross the blood-brain barrier
c) Cannot be used as an oral drug
d) Have brief duration
e) MAO and COMT act rapidly
Match the catecholamine with the receptor(s):
4.7) Isoproterenol a) α & β
4.8) Dobutamine b) β
4.9) Norepinepherine c) β1
4.10) Dopamine d) D1 & D2
4.11) Epinepherine
4.12) The basic structure of a catecholamine involves a catechol ring and which of the
following types of amines?
a) Methyl amine
b) Ethyl amine
c) Butyl amine
d) Tert-butyl amine
e) Propyl amine
Match the noncatecholamines with the receptor agonist:
4.13) Clonidine a) α1-agonist
4.14) Metaproterenol, terbutaline, ritodine b) α2-agonist
5.1) Which of the following is a long-acting (oral) α1-agonist and not a short-acting
(nasal spray, ophthalmic drops) α1-agonist?
a) Phenylephrine
b) Oxymetazoline
c) Tetrahydrazaline
d) Pseudoephedrine
5.2) Which of the following would NOT be used as a topical vasoconstrictor for a patient
with epistaxis (nasal pack soaked in drug)?
a) Phenylephrine
b) Epinepherine
c) Oymetazoline
d) Isoproterenol
5.3) α1 drugs can be given with local anesthetics to vasoconstrictor and decrease blood
flow to the side of administration. Which of the following should not be given above the
web space?
a) Phenylephrine
b) Epinephrine
c) Methoxamine
5.4) Which of the following is the α1 drug of choice (DOC) for retinal exams and
surgery, giving mydiasis (dilation of iris)?
a) Ephedrine
b) Epinepherine
c) Oymetazoline
d) Isoproterenol
e) Phenylephrine
5.5) α2-agonists are only approved for hypertension and work by decreasing sympathetic
tone and increasing vagal tone. Which of the following is NOT a α2-agonist?
a) Clonidine
b) Methyldopa
c) Guanabenz
d) Guanfacine
e) Epinephrine
5.6) At the adrenergic synapse, what does α2 do?
a) Stimulates NE release
b) Inhibits NE release
c) Stimulates ACh release
d) Inhibits ACh release
5.7) Which of the following agonists would be used for asthma patients or to delay
premature labor?
a) α2-agonist
b) α1-agonist
c) β3-agonist
d) β2-agonist
e) β1-agonist
5.8) Which of the following agonists would be used for cardiogenic shock, cardiac arrest,
heart block, or heart failure?
a) α1-agonist
b) α2-agonist
c) β1-agonist
d) β2-agonist
e) β3-agonist
5.9) Which of the following is NOT a β2-agonist?
a) Terbutaline
b) Ritodrine
c) Metaproterenol
d) Albuterol
e) Phenylepherine
5.10) β2 stimulation leads to an increase in the cellular uptake of what ion, and thus a
decrease in plasma concentration of that ion?
a) K+
b) Ca++
c) Cl-
d) Na+
e) Mg++
5.11) Dopamine receptor activation (D1) dilates renal blood vessels at low dose. At
higher doses (treatment for shock), which of the following receptor is activated?
a) α1
b) α2
c) β1
d) β2
e) β3
5.12) Which of the following responses to sympathetic stimulation would prevent
receptors from being couples with G-proteins?
a) Sequestration
b) Down-regulation
c) Phosphorylation
5.13) Which of the following is the action of the indirect-acting sympathomimetic drug
cocaine?
a) Stimulator of NET (uptake 1)
b) Inhibitor of NET (uptake 1)
c) Stimulator of VMAT (uptake 2)
d) Inhibitor of VMAT (uptake 2)
5.14) Tricyclic antidepressants (TCAs) have a great deal of side effects. Which of the
following is the action of TCAs?
a) Stimulator of NET (uptake 1)
b) Inhibitor of NET (uptake 1)
c) Stimulator of VMAT (uptake 2)
d) Inhibitor of VMAT (uptake 2)
5.15) Which of the following is NOT a mixed sympathomimetic?
a) Amphetamine
b) Methamphetamine
c) Ephedrine
d) Phenylepherine
e) Pseudoephedrine
5.16) Prior to an operation to remove a pheochromocytoma (neuroendocrine tumor of the
medulla of the adrenal glands), which of the following should be given to the patient?
a) α-agonist
b) α-blocker
c) β-agonist
d) β-blocker
5.17) Which of the following is NOT an indication for β-blocker therapy?
a) Hypotension
b) Angina pectoris
c) Arrhythmias
d) Myocardial infarction
e) Glaucoma
5.18) Which of the following β-blockers is used for decreasing aqueous humor secretions
from the ciliary body?
a) Propranolol
b) Nadolol
c) Carvedilol
d) Timolol
e) Metoprolol
5.19) Which of the following is NOT considered cardioselective?
a) Metoprolol
b) Atenolol
c) Esmolol
d) Carvedilol
5.20) Blocking α2 presynaptic receptors will do which of the following?
a) Stimulate NE release
b) Inhibit NE release
c) Stimulate DA release
d) Inhibit DA release
5.21) Which of the following drugs irreversibly damages VMAT?
a) Tyramine
b) Guanethidine
c) Reserpine
d) Propranolol
e) Epinepherine
6.1) Which of the following is the most likely to occur with parenteral administration of a
α1-agonist drug?
a) Hypotension
b) Hypertension
c) Tissue necrosis
d) Vasodilation
e) Lipolysis
6.2) Which of the following agonists can have dose-related withdrawal syndrome if the
drug is withdrawn too quickly, leading to rebound hypertension?
a) α1-agonist
b) α2-agonist
c) β1-agonist
d) β2-agonist
e) β3-agonist
6.3) Which of the following agonists can have sedation and xerostomia (dry mouth) in
50% of patients starting therapy, sexual dysfunction in males, nauseas, dizziness, and
sleep disturbances?
a) α1-agonist
b) α2-agonist
c) β1-agonist
d) β2-agonist
e) β3-agonist
6.4) Which of the following agonists can cause hyperglycemia in diabetics?
a) α2-agonist
b) α1-agonist
c) β3-agonist
d) β2-agonist
e) β1-agonist
6.5) Angina pectoris, tachycardia, and arrhythmias are possible adverse effects of which
of the following agonists?
a) α2-agonist
b) α1-agonist
c) β3-agonist
d) β2-agonist
e) β1-agonist
6.6) If a patient is taking MAO inhibitors and ingests tyramine (red wine, aged cheese),
which of the following acute responses is most likely? (sympathomimetic)
a) Stimulation of NE release
b) Inhibition of NE release
c) Stimulation of ACh release
d) Inhibition of ACh release
e) No response due to MAO inhibitor
6.7) Which of the following occurs acutely, leading to a false neurotransmitter, with
increased guanethidine? (sympathomimetic)
a) Stimulation of NE release
b) Inhibition of NE release
c) Stimulation of ACh release
d) Inhibition of ACh release
6.8) Major adverse affects of the α1 blockade include reflex tachycardia and which of the
following?
a) Orthostatic tachycardia
b) Orthostatic bradycardia
c) Orthostatic hypertension
d) Orthostatic hypotension
For questions 10 – 13, choose the correct answer from the following list. Each
answer may be used once, more than once, or not at all.
1. thiopental
2. propofol
3. ketamine
4. etomidate
5. fentanyl
Item Number: correct answer: 4 category: Anesthetics
10. The intravenous anesthetic with excitatory effects on the central nervous
system but produces the least cardiovascular disturbance among intravenous
anesthetics.
Questions 23 – 29
Choose the correct answer for the following questions from the list below.
Each answer can be used once, more than once, or not at all.
1. bretylium
2. amiodarone
3. adenosine
4. flecainide
5. lidocaine
Item Number: correct answer: 5 category: Antiarrhythmics
23. In ACLS algorithm, first antiarrhythmic to be administered in the treatment of
ventricular fibrillation refractory to defibrillation and epinephrine.
Questions 32 – 35
Choose the correct answer for the following questions from the list below.
Each answer can be used once, more than once, or not at all.
1. propranolol
2. acebutolol
3. sotalol
4. esmolol
5. butorphanol
Buprenorphine is a?
A. Partial mu agonist
B. Full mu agonist
C. Partial kappa agonist
D. Full kappa agonist
Which of the following is an integrase inhibitor currently in use for the treatment of HIV infection?
A. Indinavir
B. Elvitegravir
C. Saquinavir
D. Raltegravir